Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Suicidal Thinking in Military Patients
NCT02418702Phase 3Withdrawn
- Sponsor
- Naval Medical Center San Diego
- Start
- Aug 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in suicidal ideation, major depressive disorder (MDD), sponsored by Naval Medical Center San Diego. Planned start Aug 2016; status: withdrawn.
02
Drugs
ketamine
03
Conditions
suicidal ideationmajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02418702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02418702.